The efficacy of deep brain stimulation (DBS) for Parkinson disease (PD) is well established
for up to 1 or 2 years, but long-term outcome data are still limited. In this Review, we critically …

Objective: To provide recommendations to patients, physicians, and other health care
providers on several issues involving deep brain stimulation (DBS) for Parkinson disease …

To determine placement of electrodes after deep brain stimulation (DBS) surgery, a novel
toolbox that facilitates both reconstruction of the lead electrode trajectory and the contact …

Objective To evaluate the effects of deep brain stimulation of the subthalamic nucleus (STN-
DBS) on motor complications in patients with Parkinson disease (PD) beyond 15 years after …

Although deep brain stimulation (DBS) of the globus pallidus internus (GPi) and the
subthalamic nucleus (STN) has become an established treatment for Parkinson's disease …

Background Neurostimulation of the subthalamic nucleus reduces levodopa-related motor
complications in advanced Parkinson's disease. We compared this treatment plus …

Objective To summarize the 2010 EFNS/MDS‐ES evidence‐based treatment
recommendations for the management of P arkinson's disease (PD). This summary includes …

Objectives: Our objective was to compare long-term outcomes of deep brain stimulation
(DBS) of the globus pallidus interna (GPi) and subthalamic nucleus (STN) for patients with …

Parkinson disease (PD) is an age-related neurodegenerative disorder that affects as many
as 1–2% of persons aged 60 years and older. With the aging of the population, the …

Deep brain stimulation (DBS) is an established procedure for the symptomatic treatment of
Parkinson's disease. Several deep brain nuclei have been stimulated, producing a wide …